Analytical Data
-
Gene name
Oxy
- Application
-
Alternative Names
Three-finger toxin 3FTx-Oxy6
-
Species
Oxyuranus microlepidotus
-
Source
E. coli
-
Tag
N- His-SUMO & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A7X4T2
-
Expression Region
22-81aa
-
Molecular Weight
26.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Oxyprotein, a type of recombinant protein, has garnered significant attention in the field of biotechnology and medicine due to its versatile applications and potential therapeutic benefits. Research on Oxyproteins primarily focuses on their role in enhancing oxygen delivery and utilization in biological systems, which is crucial for a variety of medical and environmental applications. The development of Oxyproteins is rooted in the need for improved oxygenation strategies, particularly for conditions such as ischemia or chronic obstructive pulmonary disease (COPD), where oxygen supply to tissues is compromised. Advances in genetic engineering and protein expression systems have enabled scientists to produce Oxyproteins with enhanced stability and functionality, leading to promising developments in drug formulations and biomedical research. Furthermore, the study of Oxyproteins contributes to our understanding of global oxygen cycling and the physiological responses of organisms to hypoxic environments, making it an interdisciplinary focus in fields ranging from molecular biology to environmental science. As the demand for innovative therapeutic solutions continues to rise, ongoing research into Oxyproteins aims not only to optimize their production and functionality but also to explore their potential in novel therapeutic strategies, including targeted drug delivery systems and biosensors for monitoring oxygen levels in clinical settings. This growing body of research underscores the significance of Oxyproteins in addressing critical health challenges and advancing our understanding of oxygen dynamics in both human health and ecological contexts.
